HSBC Continental Europe announced that no stabilisation activities were undertaken in relation to Danone's recent bond offering totaling EUR 500 million. The bonds have fixed rates and maturities in 2028, 2031, and 2035, all offered at par value. This notice informs investors that the stabilisation manager, HSBC Continental Europe, did not intervene to support the bond prices post-offer. The announcement is informational and not an offer to buy or sell securities.
HSBC Continental Europe announced no stabilisation activities for Danone's EUR 500 million bond offering. For readers following US stocks, here is Pluang's market snapshot as of Oct 28, 2026 14:21 WIB: out of 150 priced US stocks, 54 rose and 87 fell. Notable movers include HOOD at USD 87.11 with a 1-day change of -7.88% and Pluang order activity of 5% Sell / 95% Buy, MQ at USD 19.35 up 5.56% with 0% Sell / 100% Buy, and CVE at USD 31.70 down 4.46% with 96% Sell / 4% Buy activity. Typical hold times range from 44 to 76 days on Pluang.
The global mining insurance market continues to favor buyers due to abundant capacity, strong competition, and falling rates. Rising demand for critical minerals drives investment but also increases exposure to interconnected risks like geopolitical ...
Otto Group and Sereact are introducing up to 25 AI-controlled dual-arm robots at Otto Group’s logistics center in Poland to automate the inspection and sorting of returned items. These robots use Sereact's Cortex Physical AI, powered by NVIDIA techno...
Admiral Group PLC repurchased 250,000 of its ordinary shares between October 21 and 27, 2026, as part of its ongoing buy-back program announced in September 2026. The shares were bought through UBS across multiple trading venues at prices around 3,70...
KPN's Supervisory Board has nominated Mayte Oosterveld and Natasja Laheij for appointment to the board, with votes scheduled at the April 2027 Annual General Meeting. Oosterveld brings extensive finance and strategy experience from roles at Just Eat ...
Dassault Systèmes has completed its $1.8 billion acquisition of ArisGlobal, creating a unified AI-native platform that integrates drug discovery, clinical development, manufacturing, and patient outcomes. This platform aims to accelerate innovation a...
